Antibody Drug Conjugates Market : Report Position, Recent Developments & Future Forecast Until 2024 to 2029

SKU: GMS962

Format: PDF

Overall Rating
☆☆☆☆☆ 4.5/5
Popup for Contact Form 7 required the Contact Form 7 plugin to work with.

OVERVIEW

A recent study by Global Market Studies has shown that the Antibody Drug Conjugates Market is rapidly growing at a CAGRof 26.7% and is expected to reach a value of USD 20.64 billion by 2028.

The antibody-drug conjugates (ADCs) market refers to the pharmaceuticals market for a class of targeted cancer therapies that use monoclonal antibodies to deliver cytotoxic agents directly to cancer cells. ADCs are a type of precision medicine that has shown promising results in clinical trials for the treatment of various types of cancers, including breast cancer, lymphoma and leukemia.

The global ADC market has been growing rapidly over the past few years and it is expected to continue to grow at a significant rate in the coming years. Factors driving the growth of the market include the increasing prevalence of cancer, the growing demand for targeted therapies and the ongoing development of new ADCs.

Market Dynamics

Drivers:

The rising incidence of cancer worldwide is a major driver of the ADC market. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and the number of new cancer cases is expected to increase by 50% in the next 20 years.

ADCs are highly targeted therapies that can deliver cytotoxic agents directly to cancer cells, reducing the risk of damage to healthy cells. This targeted approach has made ADCs an attractive option for cancer treatment and the demand for these therapies is expected to increase in the coming years. New technologies have enabled the production of more potent and effective ADCs.

Opportunities:

Advances in molecular biology, genomics and bioinformatics have also enabled researchers to identify new targets and develop more effective ADCs. A strong pipeline of ADC candidates in development is providing significant opportunities for growth in the ADC market. Major pharmaceutical companies are investing heavily in developing new ADCs, which is driving the market’s growth. In addition, government initiatives and funding are also contributing to the growth of the ADC market.

Restraints & Challanges:

The development and manufacturing of ADCs is complex and costly which can limit the availability and affordability of these therapies. While ADCs have shown promising results in the treatment of some types of cancer, they may not be effective in all types. This limits the potential patient population and the market for these therapies.

Like all cancer therapies, ADCs can cause side effects, including fatigue, nausea and anemia. However, the cytotoxic agents used in ADCs can also cause more severe side effects, such as liver and heart damage. Moreover, the regulatory approval process for ADCs can be complex and time-consuming, which can delay the availability of these therapies to patients.

ADCs face competition from other targeted therapies as well, such as immunotherapies and small molecule inhibitors, which can inhibit the market for these therapies.

Recent Developments:

• In December 2022, Biosion USA Inc. entered a collaboration with ImmunoGen Inc. to create antibody drug conjugates (ADCs) for the treatment of cancer. In the joint research effort, Biosion would leverage its proprietary SynTrace high-throughput (HT) endocytosis platform to generate highly selective antibodies to targets and ImmunoGen would provide its proprietary linker-payload technology to create novel ADCs.

• In September 2022, Pheon Therapeutics financed USD 68 million to develop antibody drug conjugates (ADCs) for the treatment of solid tumors.

Key Players:

Seagen Inc., ImmunoGen Inc., Mersana Therapeutics, Pfizer, F Hoffmann-La Roche Ltd, Biosion USA Inc., Pheon Therapeutics.

Frequently Asked Questions

1) What is the projected market value of the Antibody Drug Conjugates Market?

– The Antibody Drug Conjugates Market is expected to reach a value of USD 20.64 billion by 2028. 

2) What is the estimated CAGR of the Antibody Drug Conjugates Market over the 2023 to 2028 forecast period?

– The Antibody Drug Conjugates Market is expected to grow at a CAGR of approximately 26.7% from 2023 to 2028.

3) Who are the key players in the Antibody Drug Conjugates Market?

– Seagen Inc., ImmunoGen Inc., Mersana Therapeutics, Pfizer, F Hoffmann-La Roche Ltd, Biosion USA Inc, Pheon Therapeutics

Why Choose Us?

Insights into Market Trends: Global Market Studies reports provide valuable insights into market trends, including market size, segmentation, growth drivers, and market dynamics. This information helps clients make strategic decisions, such as product development, market positioning, and marketing strategies.

Competitor Analysis: Our reports provide detailed information about competitors, including their market share, product offerings, pricing, and competitive strategies. This data can be used to inform competitive strategies and to identify opportunities for growth and expansion.

Industry Forecasts: Our reports provide industry forecasts, which will inform your business strategies, such as investment decisions, production planning, and workforce planning. These forecasts can help you to prepare for future trends and to take advantage of growth opportunities.

Access to Industry Experts: Our solutions include contributions from industry experts, including analysts, consultants, and subject matter experts. This access to expert insights can be valuable for you to understand the market.

Time and Cost Savings: Our team at Global Market Studies can save you time and reduce the cost of conducting market research by providing comprehensive and up-to-date information in a single report, avoiding the need for additional market research efforts.

METHODOLOGY

At Global Market Studies, extensive research is done to create reports which have in-depth insights across all aspects of the market such as drivers, opportunities, challenges, restraints, market trends, regional insights, market segmentation, latest developments, key players for the forecast period. Multiple methods are used to derive both qualitative and quantitative information for the report:Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 1

PRIMARY RESEARCH

Through surveys and interviews, primary research is sourced mainly from experts from the core and related industry. It includes distributors, manufacturers, Directors, C-Level Executives and Managers, alliances certification organisations across various segments of the markets value chain. Both the supply-side and demand-side is interviewed.

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 2

SECONDARY RESEARCH

Our sources of secondary research include Annual Reports, Journals, Press Releases, Company Websites, Paid Databases and our own Data Repository. They also include, investor presentations, certifies publications and articles by authorised regulatory bodies, trade directories and databases.

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 3

MARKET SIZE ESTIMATION

After extensive secondary and primary research, both the Bottom-up and Top-down methods are used to analyse the data. In the Bottom-up Approach, Company revenues across multiple segments are gathered to derive the percentage split per market segment. From this the Segment wise market size is derived to give the Total Market Size. In the Top-down Approach the reverse method is used where the Total Market Size is first derived from primary sources and is split into Market Segment, Regional Split and so on.

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 4Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 5

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 6

DATA TRIANGULATION:

All statistics are collected through extensive secondary research and verified by interviews conducted with supply-side and demand-side in the primary research to ensure that both primary and secondary data percentages, statistics and findings corroborate.

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 7

Share

Get A Free Sample

Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.

Send me Free Sample

Or View Our License Options:

$3,850.00 – $5,850.00

Why

Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.

Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.

We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.

We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.

At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.

83422+ Reports Delivered

Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.

Need Customized Report ?Call Now

OVERVIEW

A recent study by Global Market Studies has shown that the Antibody Drug Conjugates Market is rapidly growing at a CAGRof 26.7% and is expected to reach a value of USD 20.64 billion by 2028.

The antibody-drug conjugates (ADCs) market refers to the pharmaceuticals market for a class of targeted cancer therapies that use monoclonal antibodies to deliver cytotoxic agents directly to cancer cells. ADCs are a type of precision medicine that has shown promising results in clinical trials for the treatment of various types of cancers, including breast cancer, lymphoma and leukemia.

The global ADC market has been growing rapidly over the past few years and it is expected to continue to grow at a significant rate in the coming years. Factors driving the growth of the market include the increasing prevalence of cancer, the growing demand for targeted therapies and the ongoing development of new ADCs.

Market Dynamics

Drivers:

The rising incidence of cancer worldwide is a major driver of the ADC market. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and the number of new cancer cases is expected to increase by 50% in the next 20 years.

ADCs are highly targeted therapies that can deliver cytotoxic agents directly to cancer cells, reducing the risk of damage to healthy cells. This targeted approach has made ADCs an attractive option for cancer treatment and the demand for these therapies is expected to increase in the coming years. New technologies have enabled the production of more potent and effective ADCs.

Opportunities:

Advances in molecular biology, genomics and bioinformatics have also enabled researchers to identify new targets and develop more effective ADCs. A strong pipeline of ADC candidates in development is providing significant opportunities for growth in the ADC market. Major pharmaceutical companies are investing heavily in developing new ADCs, which is driving the market’s growth. In addition, government initiatives and funding are also contributing to the growth of the ADC market.

Restraints & Challanges:

The development and manufacturing of ADCs is complex and costly which can limit the availability and affordability of these therapies. While ADCs have shown promising results in the treatment of some types of cancer, they may not be effective in all types. This limits the potential patient population and the market for these therapies.

Like all cancer therapies, ADCs can cause side effects, including fatigue, nausea and anemia. However, the cytotoxic agents used in ADCs can also cause more severe side effects, such as liver and heart damage. Moreover, the regulatory approval process for ADCs can be complex and time-consuming, which can delay the availability of these therapies to patients.

ADCs face competition from other targeted therapies as well, such as immunotherapies and small molecule inhibitors, which can inhibit the market for these therapies.

Recent Developments:

• In December 2022, Biosion USA Inc. entered a collaboration with ImmunoGen Inc. to create antibody drug conjugates (ADCs) for the treatment of cancer. In the joint research effort, Biosion would leverage its proprietary SynTrace high-throughput (HT) endocytosis platform to generate highly selective antibodies to targets and ImmunoGen would provide its proprietary linker-payload technology to create novel ADCs.

• In September 2022, Pheon Therapeutics financed USD 68 million to develop antibody drug conjugates (ADCs) for the treatment of solid tumors.

Key Players:

Seagen Inc., ImmunoGen Inc., Mersana Therapeutics, Pfizer, F Hoffmann-La Roche Ltd, Biosion USA Inc., Pheon Therapeutics.

Frequently Asked Questions

1) What is the projected market value of the Antibody Drug Conjugates Market?

– The Antibody Drug Conjugates Market is expected to reach a value of USD 20.64 billion by 2028. 

2) What is the estimated CAGR of the Antibody Drug Conjugates Market over the 2023 to 2028 forecast period?

– The Antibody Drug Conjugates Market is expected to grow at a CAGR of approximately 26.7% from 2023 to 2028.

3) Who are the key players in the Antibody Drug Conjugates Market?

– Seagen Inc., ImmunoGen Inc., Mersana Therapeutics, Pfizer, F Hoffmann-La Roche Ltd, Biosion USA Inc, Pheon Therapeutics

Why Choose Us?

Insights into Market Trends: Global Market Studies reports provide valuable insights into market trends, including market size, segmentation, growth drivers, and market dynamics. This information helps clients make strategic decisions, such as product development, market positioning, and marketing strategies.

Competitor Analysis: Our reports provide detailed information about competitors, including their market share, product offerings, pricing, and competitive strategies. This data can be used to inform competitive strategies and to identify opportunities for growth and expansion.

Industry Forecasts: Our reports provide industry forecasts, which will inform your business strategies, such as investment decisions, production planning, and workforce planning. These forecasts can help you to prepare for future trends and to take advantage of growth opportunities.

Access to Industry Experts: Our solutions include contributions from industry experts, including analysts, consultants, and subject matter experts. This access to expert insights can be valuable for you to understand the market.

Time and Cost Savings: Our team at Global Market Studies can save you time and reduce the cost of conducting market research by providing comprehensive and up-to-date information in a single report, avoiding the need for additional market research efforts.

METHODOLOGY

At Global Market Studies, extensive research is done to create reports which have in-depth insights across all aspects of the market such as drivers, opportunities, challenges, restraints, market trends, regional insights, market segmentation, latest developments, key players for the forecast period. Multiple methods are used to derive both qualitative and quantitative information for the report:Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 1

PRIMARY RESEARCH

Through surveys and interviews, primary research is sourced mainly from experts from the core and related industry. It includes distributors, manufacturers, Directors, C-Level Executives and Managers, alliances certification organisations across various segments of the markets value chain. Both the supply-side and demand-side is interviewed.

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 2

SECONDARY RESEARCH

Our sources of secondary research include Annual Reports, Journals, Press Releases, Company Websites, Paid Databases and our own Data Repository. They also include, investor presentations, certifies publications and articles by authorised regulatory bodies, trade directories and databases.

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 3

MARKET SIZE ESTIMATION

After extensive secondary and primary research, both the Bottom-up and Top-down methods are used to analyse the data. In the Bottom-up Approach, Company revenues across multiple segments are gathered to derive the percentage split per market segment. From this the Segment wise market size is derived to give the Total Market Size. In the Top-down Approach the reverse method is used where the Total Market Size is first derived from primary sources and is split into Market Segment, Regional Split and so on.

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 4Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 5

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 6

DATA TRIANGULATION:

All statistics are collected through extensive secondary research and verified by interviews conducted with supply-side and demand-side in the primary research to ensure that both primary and secondary data percentages, statistics and findings corroborate.

Silicon battery market by capacity (0–3,000 mah, 3,000–10,000 mah, 10,000–60,000 mah, and 60,000 mah & above), application (consumer electronics, automotive, aviation, energy, and medical devices), and region - 2023 to 2028 7

Download our eBook: Market Mastery

Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.

Download Free Ebook

Related Research Reports

Related products